Introduction {#s1}
============

Status epilepticus (SE) is characterized by prolonged seizures or by multiple seizures without full restoration of consciousness between events [@pone.0047474-Working1]. The condition is associated with significant morbidity and mortality. SE is thought to have a fatality rate of approximately 2% [@pone.0047474-Sillanpaa1], [@pone.0047474-Wu1]. Complications of SE are also significant and include refractory epilepsy, neurologic deficits and repeated episodes of SE [@pone.0047474-Sahin1].

While a number of studies have identified associations for poor outcomes in SE [@pone.0047474-Koubeissi1], [@pone.0047474-Logroscino1], the use of publically available hospital databases with large sample sizes may allow for better determination of morbidity and mortality risk factors for patients with this condition. In this study, we investigate potential risk factors leading to death in children presenting with generalized convulsive SE.

Patients and Methods {#s2}
====================

Study Population {#s2a}
----------------

This study utilized patient data acquired from the Kids\' Inpatient Database (KID). The KID dataset has been set up through the Healthcare Cost and Utilization Project (HCUP) and is the only all-payer inpatient care database for children in the United States. Data from both insured and uninsured pediatric patients, defined as individuals less than 20 years of age, are collected. Data collected from KID include demographic information, including patient age, gender, race, median income and ZIP code, primary and secondary diagnoses, procedures, payment information, and patient length of stay. KID also collects information on factors including hospital size, teaching status, type of hospital and hospital location. We used data from the years 1997, 2000, 2003 and 2006. The 1997 database includes data from 2,521 hospitals in 22 states, the 2000 database includes data from 2,784 hospitals in 27 states, the 2003 database includes data from 3,438 hospitals in 36 states, and the 2006 database includes data from 3,739 hospitals in 38 states. Twenty percent of normal newborn births and 80% of the inpatient admissions from each institution are included in the dataset as a systematic random sample [@pone.0047474-Agency1].

Standard Protocol Approvals {#s2b}
---------------------------

Prior to data analysis, the Institutional Review Boards of Case Western Reserve University and University Hospitals, Cleveland, OH, and Boston Children\'s Hospital, Boston, MA, granted exempt status to this study. Informed consent was not required. This study was done in accordance with the HCUP user agreement.

Data Acquisition {#s2c}
----------------

We queried KID for cases with a diagnostic code of generalized convulsive status epilepticus via usage of the International Statistical Classification of Diseases and Related Health Problems, 9^th^ revision (ICD-9) code 345.3. This code corresponds to "grand mal status". No other ICD-9 codes were used. Data pertaining to month of admission, admission source (from the emergency room, at birth, from outside the hospital and from outside the facility), sex, elective admission or not, age, length of stay, ethnicity, income level (assessed as median income per ZIP code), hospital type (general hospital, children\'s hospital, or general hospital with a children\'s unit), hospital bed size, hospital location (rural versus urban and geographic region), and teaching status of hospital were collected. We also used ICD-9 codes to collect data pertaining to patient comorbidities, interventions and complications ([table 1](#pone-0047474-t001){ref-type="table"}). Outcomes pertaining to mortality, which were listed separately in the KID dataset, were collected for each patient.

10.1371/journal.pone.0047474.t001

###### Univariate calculations of complications and comorbidities from the KID database.
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  Predictor                                                       ICD-9 Code                          Total N   Predictor N    OR     Lower 95%   Upper 95%     *P*
  ---------------------------------------- --------------------------------------------------------- --------- ------------- ------- ----------- ----------- ---------
  ***Metabolic***                                                                                                                                            
  Hyponatremia                                                       276.1                             12360        238       3.31      1.52        7.18       0.002
  Hypoxia                                        799.0, 770.8, 768, 348.1, 768.5, 768.6, 768.9         12360        293       12.35     8.01        19.04     \<.001
  Drug overdose                                                       966                              12360        12         \-        \-          \-      
  Hepatic encephalopathy                                             572.2                             12360       \<10        \-        \-          \-         \-
  Metabolic derangements                                          277, 348.31                          12360        105       4.26      1.54        11.76      0.005
  Severe malnutrition                                         260, 261, 262, 263                       12360        60        3.65      0.88        15.14      0.074
  Toxic                                             349.82, 323.7, 983, 984, 985, 988, 989             12360        19         \-        \-          \-         \-
  Hypoglycemia                                     250.8, 251.0, 251.1, 251.2, 300.19, 775.6           12360        67        8.77      3.46        22.23     \<.001
  Drug withdrawal                                                292.0, 779.5                          12360       \<10        \-        \-          \-         \-
  ***Infectious***                                                                                                                                           
  Sepsis                                               038, 771.8, 995.91 995.92, 771.81               12360        44        33.56     16.17       69.66     \<.001
  Cerebral malaria                                                   084.9                             12365       \<10        \-        \-          \-         \-
  Disseminated tuberculosis                                           018                               \-          \-         \-        \-          \-         \-
  Acute viral encephalitis                           049.9, 062, 064, 139.0, 323.0, 323.01             12360        34        10.37     3.12        34.40     \<0.001
  Central nervous system infections                                 V12.42                             12365       \<10        \-        \-          \-         \-
  Meningoencephalitis                                            323.0, 323.4                          12360       \<10        \-        \-          \-         \-
  Bacterial meningitis                             320, 320.7, 320.8, 320.81, 320.82, 320.9            12360       \<10        \-        \-          \-         \-
  Infectious encephalopathy                               136.9, 323.5, 323.9, 348.3                   12360        394       2.57      1.29        5.10      \<.007
  Severe malaria                                 084, 084.9, 084.4, 084.5, 084.6, 084.7, 084.8         12330        \-         \-        \-          \-         \-
  Pneumonia                                   480, 480.8, 480.9, 481, 482, 482.8, 483, 485, 011.6      12360        51        6.69      2.05        21.78      0.002
  Meningitis                                013.0, 036.0, 320, 047.8, 047.9, 320.1, 321, 320.8, 322    12360        44         \-        \-          \-         \-
  Bacteremia                                                     790.7, 771.83                         12360        58         \-        \-          \-         \-
  Viral encephalitis                                  062, 063, 064, 139.0, 323.0, 049.9               12360        34        10.37     3.12        34.39     \<.001
  RSV infection                                                      079.6                             12360        42        2.57      0.35        18.81      0.354
  Postoperative sepsis and liver failure                            998.59                             12360        26        59.93     26.14      137.42     \<.001
  Septic shock                                                  785.52, 785.59                         12360        46        57.93     30.35      110.59     \<.001
  ***Hemodynamic***                                                                                                                                          
  Congenital heart disease                                           746.9                             12360       \<10        \-        \-          \-         \-
  Hypotension                                   458, 458.0, 458.1, 458.2, 458.29, 458.8, 458.9         12360        146       15.96     9.28        27.47     \<.001
  Intractable hypertension                                401, 403, 403.0, 405, 405.0                  12360        104       5.48      2.19        13.71     \<.001
  Cardiac failure                                                    428.9                             12360       \<10        \-        \-          \-         \-
  Hemorrhagic shock                                              785.59, 958.4                         12360        29        50.93     22.67      114.39     \<.001
  Post cardiac arrest                                                997.1                             12360       \<10        \-        \-          \-         \-
  ***Neurologic***                                                                                                                                           
  Cerebral palsy                             333.71, 343, 343.0, 343.1, 343.2, 343.3, 343.8, 343.9     12360       2132       0.64      0.37        1.12       0.118
  Subdural Hematoma                                              432.1, 767.0                          12360        21        11.19     2.58        48.59     \<0.001
  Cerebrovascular accident                                  434.01, 434.11, 434.91                     12360        36        37.07     17.32       82.07     \<.007
  Brain trauma                                           850, 767.0, 850.9 854, 310.2                  12360        14         \-        \-          \-         \-
  Acute cerebrovascular disease                 436, 437, 437.1, 437.8, 437.9 438, 438.8, 438.9        12360        46        2.34      0.32        17.10      0.403
  Brain death                                                        348.8                             12360        119       9.19      4.54        18.61     \<.001
  Brainstem tumor                                                191.7, 225.9                          12360       \<10        \-        \-          \-         \-
  Structural brain lesion                                            348.8                             12360        119       9.19      4.54        18.61     \<.001
  Intracranial hemorrhage                                        800.3, 800.8                          12360       \<10        \-        \-          \-         \-
  Brainstem herniation                                               348.4                             12360        33        24.46     9.90        60.40     \<.001
  Epilepsy                                                            345                              12360        376       0.84      0.26        2.65       0.763
  Generalized Convulsive Epilepsy                                    345.1                             12360        38         \-        \-          \-         \-
  Generalized Non-Convulsive Epilepsy                                345.0                             12360        19         \-        \-          \-         \-
  Infantile spasms                                                   345.6                             12360       \<10        \-        \-          \-         \-
  Hydrocephalus                                                       331                              12360        832       0.62      0.25        1.51       0.291
  Obstructive hydrocephalus                                          331.4                             12360        472       0.89      0.33        2.42       0.821
  Communicating hydrocephalus                                        331.3                             12360        16         \-        \-          \-         \-
  Idiopathic hydrocephalus                                           331.5                             12360       \<10        \-        \-          \-         \-
  Congenital hydrocephalus                                           742.3                             12360        349       0.30      0.04        2.12       0.224
  CNS Malformation in fetus                                          655.0                             12360       \<10        \-        \-          \-         \-
  Tuberous sclerosis                                                 759.5                             12360        124       0.85      0.12        6.13       0.871
  Rasmussen encephalitis                                            323.81                             12360       \<10        \-        \-          \-         \-
                                                                  ***Other***                                                                                
  Non compliance                                                    V15.81                             12360       \<10        \-        \-          \-         \-
  Near drowning                                                      994.1                             12360       \<10       26.38     2.93       237.80      0.004
  Congenital malformations                                       V13.6, V13.69                         12360       \<10        \-        \-          \-         \-
  Massive aspiration                                      507, 770.1, 770.18, E879.4                   12360        711       2.25      1.28        3.96       0.005
  Esophageal tear                                                   530.89                             12360       \<10        \-        \-          \-         \-
  Fever                                                              780.6                             12360        612       1.04      0.45        2.37       0.929
  **Interventions**                                                                                                                                          
  Transfusion                                                    99.01--99.09                          12360        110       36.48     22.21       59.93     \<0.001
  Ventriculoperitoneal shunt                                      2.31--2.39                           12360        23        4.79      0.64        35.82      0.127
  Intubation                                                         96.04                             12360        19         \-        \-          \-         \-
  Mechanical ventilation                                             96.71                             12360       3351       12.64     7.87        20.30     \<0.001
  Mechanical ventilation 96 hours                                    96.72                             12360        426       22.74     15.53       33.30     \<0.001

ICD-9 -- International Classification of Disease, 9th edition, RSV -- respiratory syncytial virus.

Statistical Analysis {#s2d}
--------------------

Univariate logistic testing was used to screen for significant risk factors of death. Risk factors with an associated *p-*value less than 0.20 were entered into a stepwise backwards conditional multivariable logistic regression procedure. The multivariable model only retained risk factors with an associated *p-*value less than 0.05. Two-way interaction terms were entered one at a time into the resulting multivariable model and were retained if the associated *p-*value was less than 0.05. Model validity was assessed using the Hosmer and Lemeshow goodness-of-fit test with *p-*value greater than 0.05 indicating adequate model fit of data. All statistical analyses were performed in Stata 11.0 (Statacorp, College Station, TX).

Results {#s3}
=======

Description of Patient Population and Mortality Rate {#s3a}
----------------------------------------------------

A total of 14,965,571 patients were included based on the KID datasets from 1997, 2000, 2003 and 2006. Of these, 12,365 patients (0.083%) were diagnosed with convulsive SE, including 5,541 (44.8%) girls. Five patients (\<0.0001%) were excluded from the study due to insufficient data for the tested variables. Mean patient age was 6.2±5.5 years (range \<1--20 years, median 5 years). One-hundred-and-seventeen patients (0.95%) with convulsive SE died during their inpatient admission. Additional demographic data are provided in [table 2](#pone-0047474-t002){ref-type="table"}.

10.1371/journal.pone.0047474.t002

###### Patient Population.
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  Total patient population         14,965,571
  ---------------------------- ------------------
  Cases of Convulsive SE (%)    12,365 (0.083%)
  Number of Females with SE      5,541 (44.8%)
  Mean Age (SD; range)          6.2 (5.5; 0--20)
  Deaths in SE Cases              117 patients
  Case Fatality Rate                 0.95%

  Patient Demographics         *patients*   *percent*
  --------------------------- ------------ -----------
  Caucasian                      4,697       49.11%
  African American               1,943       20.35%
  Hispanic                       2,044       21.37%
  Asian or Pacific Islander       275         2.88%
  Native American                  71         0.74%
  Other                           531         5.55%

SE -- Status epilepticus; SD -- standard deviation.

Risk Factor Analysis {#s3b}
--------------------

Logistic testing was done to identify potential risk factors for death in convulsive status epilepticus, and those risk factors associated with a *p-*value of 0.20 were entered into a multivariate model. Factors with a *p-*value of less than 0.05 were taken as significant following model verification. Univariate and multivariate calculations are provided in [tables 1](#pone-0047474-t001){ref-type="table"}, [3](#pone-0047474-t003){ref-type="table"} and [4](#pone-0047474-t004){ref-type="table"}.

10.1371/journal.pone.0047474.t003

###### Univariate calculations of hospital and demographic data from the KID database.
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  Predictor                                 Total N   Predictor N    OR    Lower 95%   Upper 95%     *P*
  ---------------------------------------- --------- ------------- ------ ----------- ----------- ---------
  January Admission                          12360        957       1.00                          
  February Admission                         12360        983       1.95     0.67        5.74       0.22
  March Admission                            12360        992       2.13     0.74        6.16       0.16
  April Admission                            12360        878       1.97     0.66        5.90       0.23
  May Admission                              12360        963       1.59     0.52        4.89       0.42
  June Admission                             12360        934       1.85     0.62        5.54       0.27
  July Admission                             12360        935       1.44     0.45        4.54       0.54
  August Admission                           12360        899       2.14     0.73        6.28       0.17
  September Admission                        12360        883       1.08     0.31        3.75       0.90
  October Admission                          12360        999       1.73     0.58        5.18       0.33
  November Admission                         12360        963       0.99     0.29        3.44       0.99
  December Admission                         12360       1042       4.11     1.55        10.89      0.01
  **Admission Source**                      121999                                                
  Emergency room                                         7674       1.00      \-          \-         \-
  Birth                                                  2197       1.53     0.94        2.48       0.084
  Outside Hospital                                       2042       2.07     1.32        3.23       0.001
  Outside Facility                                        286       2.46     0.98        6.21       0.055
  Weekend Admission                          12146       3389       1.36     0.93        2.00       0.114
  Female                                     12360       5537       1.17     0.81        1.69       0.392
  Elective Admission                         11333        738       1.34     0.67        2.66       0.48
  Age in years (if more than 1 year old)     12319        \-        1.03     0.99        1.06       0.108
  Age in Days (if less than 1 year old)       801         \-        1.00     0.99        1.00       0.327
  Length of Stay                             12360        \-        1.03     1.02        1.04      \<0.001
  **Race**                                   12360                                                
  White                                                  4697       1.00                          
  Black                                                  1943       0.49     0.24        1.01       0.053
  Hispanic                                               2044       0.78     0.43        1.41       0.412
  Other                                                  3676       1.43     0.95        2.15       0.088
  **Urban/Rural by ZIP Code**                7506                                                 
  Large                                                  4306       1.00                          
  Small                                                  2187       1.27     0.76        2.10       0.361
  Metropolitan                                            638       1.21     0.54        2.73       0.639
  Non-core                                                375       1.18     0.42        3.32       0.754
  **Income per ZIP Code**                    12006                                                
  1^st^ quartile                                         3076       1.00                          
  2^nd^ quartile                                         3133       1.11     0.64        1.92       0.722
  3^rd^ quartile                                         2776       1.53     0.90        2.59       0.115
  4^th^ quartile                                         3012       1.28     0.74        2.19       0.376
  **Hospital Type**                          11693                                                
  General                                                4897       1.00                          
  General with children\'s unit                          4125       1.60     1.01        2.54       0.045
  Children\'s                                            2671       2.14     1.32        3.44       0.002
  **Hospital Bed Size**                      11936                                                
  Small                                                  1696       1.00                          
  Medium                                                 3430       1.20     0.64        2.25       0.563
  Large                                                  6810       1.16     0.65        2.07       0.62
  Urban Hospital                             11936       11265      3.33     0.82        13.51      0.092
  **Hospital Region**                        12360                                                
  Northeast                                              2528       1.00                          
  Midwest                                                2488       1.39     0.77        2.53       0.273
  South                                                  4125       1.13     0.65        1.98       0.669
  West                                                   3219       1.54     0.88        2.68       0.13
  Teaching Hospital                          11936       9156       2.16     1.23        3.79       0.007

10.1371/journal.pone.0047474.t004

###### Significant risk factors for death in pediatric patients with convulsive status epilepticus following multivariate analysis.
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  Predictor                                      Odds Ratio   *P* Value   Lower 95%   Upper 95%
  --------------------------------------------- ------------ ----------- ----------- -----------
  **African American Race**                         0.36        0.009       0.17        0.78
  **December Admission**                            3.38       \<0.001      2.01        5.67
  **Admission Source**                                                               
  **Emergency Room**                                1.00         \-          \-          \-
  **Birth**                                         1.34        0.279       0.79        2.29
  **Outside Hospital**                              1.58        0.073       0.96        2.60
  **Outside Facility**                              2.05        0.159       0.75        5.56
  **Comorbidities**                                                                  
  **Sepsis**                                       10.14       \<0.001      4.02        25.57
  **Hypoglycemia**                                  5.79        0.004       1.75        19.16
  **Near Drowning**                                43.17        0.001       4.37       426.82
  **Hemorrhagic Shock**                            17.83        0.001       6.47        49.12
  **Structural Brain Lesion**                       7.01       \<0.001      3.07        15.98
  **Massive Aspiration**                            9.11        0.008       1.77        47.01
  **Postoperative Sepsis with Liver Failure**      14.44       \<0.001      4.98        41.86
  **Procedures**                                                                     
  **Transfusion**                                   8.25       \<0.001      4.32        15.78
  **Mechanical Ventilation**                        9.03       \<0.001      5.59        14.60
  **\>72 hours**                                                                     

Risk Factors Based on Demographic Data {#s3c}
--------------------------------------

African American children were at a significantly lower risk of mortality following an episode of convulsive SE (p = 0.009). Patients in other racial groups did not have an associated increase or decrease in mortality. No association was found between patient age and mortality risk. Household income, calculated as the average income in a ZIP code region, was also not a significant risk factor for death.

Risk Factors Based on Hospital Admission {#s3d}
----------------------------------------

Using univariate analysis, cases referred from outside hospitals were associated with a higher rate of mortality, as were Children\'s Hospitals, Teaching Hospitals, and General Hospitals with a Children\'s Unit. These findings were not significant in multivariate analysis. Patient length of stay, weekend versus weekday admission, hospital size and geographic region of hospital were not associated with an increased risk of mortality. None of these factors emerged as significant in multivariate analysis.

Risk Factors Based on Comorbidities {#s3e}
-----------------------------------

A number of patient comorbidities corresponded to a greater mortality risk in convulsive SE. Sepsis (p\<0.001), hypoglycemia (p = 0.004), near-drowning episode (p = 0.001), hemorrhagic shock (p\<0.001), structural brain lesions (p\<0.001), massive aspiration (p = 0.008), and postoperative sepsis with liver failure (p\<0.001) were associated with increased mortality. Though risk factors such as hypertension, subdural hemorrhage, viral encephalitis, and infectious encephalopathy were significant risk factors in univariate analysis, they did not emerge as significant factors following multivariate calculations. Other comorbidities, including a previous diagnosis of epilepsy, antiepileptic medication withdrawal, fever, esophageal tears, post-cardiac arrest status, brainstem tumors, infantile spasms, other encephalitis, and hydrocephalus were not associated with increased mortality.

Risk Factors Based on Procedures {#s3f}
--------------------------------

The need for blood transfusion was associated with greater risk of death (p\<0.001). While intubation was not a risk factor for death, mechanical ventilation for more than 96 hours was associated with a higher mortality (p\<0.001). Ventriculoperitoneal shunt placement was not associated with higher mortality.

Discussion {#s4}
==========

Summary {#s4a}
-------

This retrospective study utilized the KID dataset to identify a number of risk factors for poor outcome in pediatric patients diagnosed with convulsive status epilepticus. Higher risk was associated with end-of-year hospital admissions, various patient-related comorbidities, blood transfusion and prolonged mechanical ventilation. African American ethnicity was associated with a lower risk of mortality. A review of the literature is presented in [table 5](#pone-0047474-t005){ref-type="table"}.

10.1371/journal.pone.0047474.t005

###### Selected historical studies of status epilepticus with salient findings.
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  Author, Year and Study Design                                                                        Follow up                                     Mortality rate                                                                               Predictors/Risk Factors
  ----------------------------------------------------------------------------------------------- -------------------- -------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------
  Aicardi et al, 1970 [@pone.0047474-Aicardi1] *Retrospective*                                      DischargeUnclear                           4.2% (10/239)11% (27/239)                                                                      Prolonged SE, cerebral disease
  Chevrie et al, 1978 [@pone.0047474-Chevrie1] *Prospective*                                          \<4 year f/u                                21/334 in 1^st^ year                                                                     Symptomatic seizures, age \<6 months
  Dunn et al, 1988 [@pone.0047474-Dunn1] *Prospective*                                                 Discharge                                      8.24% (8/97)                                                            Severe pre-existing brain damage, meningitis and encephalopathy
  Maytal et al, 1989 [@pone.0047474-Maytal1] *Retrospective with prospective follow-up*               13.2 months                                     7.2% (7/97)                                                                                      Prolonged SE
  DeLorenzo et al, 1992 [@pone.0047474-DeLorenzo1] *Retrospective and prospective*                      7 years                              2.3% of children25% in adults                                             Tumor, hematological disease, anoxia, metabolic and congenital malformations
  Scholtes et al, 1996 [@pone.0047474-Scholtes1] *Retrospective*                                       Discharge                                     11.5% (13/112)                                              Anoxia, presence of \>1 complication, insufficient therapy, prolonged duration (\>8 hrs)
  Logroscino et al, 1997 [@pone.0047474-Logroscino1] *Retrospective*                                    19 years                                      21% (38/184)                                                                              \<1 year age, acute illness
  Barnard et al, 1999 [@pone.0047474-Barnard1] *Retrospective*                                     Discharge53 months                           9.6% (5/52)15.4% (8/52)                                                            Brain tumors, metabolic disorder, multi-organ failure
  Mah et al, 1999 [@pone.0047474-Mah1] *Retrospective*                                                  5 years                               2% SE group1.5% in NSE group                                              Drug overdose, sepsis, disseminated tuberculosis, congenital heart disease
  Waterhouse et al, 1999 [@pone.0047474-Waterhouse1] *Prospective*                                         \-                               17.8% (5.2 in pediatric and 24%)                                                      CNS infection, hypoxia, drug withdrawal, continuous SE
  Berg et al, 2001 [@pone.0047474-Berg1] *Prospective*                                                  4 years                                      1.6% (10/613)                                                              Neurodegenerative conditions, coexisting medical conditions
  Callenbach et al, 2001 [@pone.0047474-Callenbach1] *Retrospective*                                    4 years                                       1.9% (9/472)                                                        Respiratory insufficiency, RSV infection, aspiration, brain herniation
  Kim et al, 2001 [@pone.0047474-Kim1] *Case series*                                                    4 years                                      43.5% (10/23)                                                                     Acute symptomatic etiology, especially anoxia
  Sahin et al, 2001 [@pone.0047474-Sahin1]Retrospective                                                 8 years                                       31.8% (7/22)                                                                   Remote symptomatic and progressive encephalopathy
  Tabarki et al, 2001 [@pone.0047474-Tabarki1] *Retrospective*                                          7 years                                      15.8% (22/139)                                                                Acute symptomatic seizure, progressive encephalopathy
  Logroscino G et al 2002 [@pone.0047474-Logroscino3] *Retrospective*                                   Unclear                                           43%                                                                Prolonged SE (\>24 hr), acute symptomatic etiology, myoclonic SE
  Ogutu et al, 2002 [@pone.0047474-Ogutu1] *Pharmacokinetics and clinical effects measurements*        Discharge                                      13.1% (5/38)                                                                  Intracranial hypertension, intractable convulsions
  Sillanpää et al, 2002 [@pone.0047474-Sillanpaa1] *Prospective*                                     Long follow up                                   16% (24/150)                                            Remote symptomatic cause, young patient (\<6 yrs), partial seizures, history of febrile seizure
  Singhi et al, 2002 [@pone.0047474-Singhi1] *Prospective*                                             Discharge                                      25% (10/40)                                            Early intubation and ventilation, meningoencephalitis, acute hyponatremia, hepatic encephalopathy
  Wu et al, 2002 [@pone.0047474-Wu1] *Retrospective*                                                   Discharge                                     1.9% (55/2885)                                                                            Female sex, older age (\>75)
  KarasalIhoGlu et al, 2003 [@pone.0047474-KarasalIhoGlu1] *Retrospective*                              1 month                                       7.2% (6/83)                                        Polypharmacy, discontinuation of AEDs, neuromotor retardation, generalized background abnormality on EEG
  Berg et al, 2004 [@pone.0047474-Berg2] *Prospective*                                                  Unclear                                      2.1% (13/613)                                                          Neurodegenerative disorder ± epileptic encephalopathy, prolonged SE
  Chin et al, 2004 [@pone.0047474-Chin1] *Retrospective*                                               Discharge                                      5.1% (5/98)                                                Younger age, intubation, CNS infection, hyponatremia, hypoxia, sepsis, subdural hematoma
  Asadi-Pooya et al, 2005 [@pone.0047474-AsadiPooya1] *Retrospective*                                  Discharge                                     10.4% (14/135)                                      Prolonged febrile seizure, CNS infection, metabolic/AED withdrawal, symptomatic epilepsy, prolonged stay
  Brevoord et al, 2005 [@pone.0047474-Brevoord1] *Retrospective*                                       Discharge                                      5.7% (7/205)                                 Near drowning episode, pneumococcal meningitis, cardiac failure, brainstem tumor, hemorrhagic shock, metabolic defect
  Gulati et al, 2005 [@pone.0047474-Gulati1] *Retrospective*                                           Discharge                                       30% (9/30)                                                                          Prolonged SE (\>45 min), septic shock
  Kang et al, 2005 [@pone.0047474-Kang1] *Retrospective*                                                Unclear                                            3%                                                              Higher mortality in acute symptomatic SE versus remote symptomatic SE
  Maegaki et al, 2005 [@pone.0047474-Maegaki1] *Retrospective*                                         Discharge                                      3.8% (9/241)                                                                     Prolonged SE (\>2 hr), moderate-severe asthma
  Ozdemir et al, 2005 [@pone.0047474-Ozdemir1] *Retrospective*                                         Discharge                                       19% (5/27)                                                          Acute symptomatic SE, progressive encephalopathy, underlying disease
  Ahmad et al, 2006 [@pone.0047474-Ahmad1] *Randomized controlled trial*                               Discharge                                    17.5% (N = 160)                                  Progressive infection, cerebral malaria, febrile convulsions, acute bacterial meningitis, metabolic derangements
  Chen et al, 2006 [@pone.0047474-Chen1] *Population based study*                                      Discharge                                      3.1% (7/226)                                           Febrile illness, acute bacterial meningitis, progressive neurological disorders, intermittent SE.
  Morrison et al, 2006 [@pone.0047474-Morrison1] *Retrospective*                                       Discharge                                       18% (3/17)                                                                 Subdural hematoma, birth asphyxia, post-cardiac arrest
  Hayashi et al, 2007 [@pone.0047474-Hayashi1] *Retrospective*                                         Discharge                                     2.1% (10/479)                                                                         Encephalitis, cerebrovascular disease
  Muchochi et al, 2007 [@pone.0047474-Muchohi1] *Non-randomized controlled*                            Discharge                                     11.54% (3/26)                                                                      Pre-existing cerebral malaria, convulsions
  Mpimbaza et al, 2008 [@pone.0047474-Mpimbaza1] *Randomized controlled trial*                         Discharge                                      6% (20/330)                                                               Malaria, severe malnutrition, immunosuppression, pneumonia
  Sadarangani et al, 2008 [@pone.0047474-Sadarangani1] *Retrospective*                                 Discharge        Confirmed convulsive SE: 19% (11/58)Probable convulsive SE: 11% (13/120)                       Acute bacterial meningitis, age \<1 year, hypoglycemia, focal onset seizures
  Siddiqui et al, 2008 [@pone.0047474-Siddiqui1] *Retrospective*                                       Discharge                                      12% (15/125)                                                     Acute intracranial infections, age \<5 years, prolonged SE (5.93±5.76 hours)
  Lin et al, 2009 [@pone.0047474-Lin1] *Retrospective*                                             Stay in ICUUnclear                         8.51% (12/141)9.2% (13/141)                                                                             Febrile illness
  Mei Li et al, 2009 [@pone.0047474-Li1] *Retrospective*                                                1 month                                      15.8% (32/203)                                           Mechanical ventilation, complications, SE duration after admission, hyponatremia, recurrent SE
  Molinero et al, 2009 [@pone.0047474-Molinero1] *Prospective*                                         Discharge                                       13% (6/47)                                                            Infectious cause, cerebrovascular accident, long seizure duration

AED -- antiepileptic drug; SE -- status epilepticus; CNS -- central nervous system; ICU -- intensive care unit; RSV -- respiratory syncytial virus.

Mortality rate {#s4b}
--------------

The mortality rates of convulsive SE in previous studies vary. Some studies report a less than 2% mortality [@pone.0047474-Sillanpaa1], [@pone.0047474-Wu1] whereas other studies provide figures over 30% [@pone.0047474-Gulati1]. The mortality rate of convulsive SE in our study was approximately 1%. This finding corresponds to mortality rates from previous research. A state-wide study based in California utilized a dataset including over 19,000 adults and children admitted for SE and found an in-hospital mortality rate of 1.9% [@pone.0047474-Wu1]. A prospective study evaluating intractable epilepsy in 613 children found a death rate of 1.6% over 4 years [@pone.0047474-Berg1]. Another prospective study found a mortality rate of 2% in 47 pediatric patients with SE [@pone.0047474-Mah1]. Studies with higher mortality rates may have analyzed high-risk subgroups, such as SE patients with pediatric intensive care unit (ICU) admissions [@pone.0047474-Gulati1] or cases of refractory SE only [@pone.0047474-Ozdemir1]. Because prolonged seizures are thought to be a risk factor for complications and death, studies that maintained criteria of a minimum seizure length of 30 or more minutes may have subsequently reported higher fatality rates [@pone.0047474-Aicardi1], [@pone.0047474-Dunn1]. Investigators who studied mortality over months to years of follow-up reported higher fatality rates [@pone.0047474-Aicardi1]. Most studies of SE do not specifically investigate pediatric patients. Because the mortality of SE may rise with age [@pone.0047474-Koubeissi1], [@pone.0047474-DeLorenzo1], the inclusion of adult patients can result in a higher case-fatality rate. However, the age-specific incidence of epilepsy is highest in infancy and early childhood and decreases progressively as children grow up [@pone.0047474-Banerjee1].

Demographic data {#s4c}
----------------

### Race {#s4c1}

Children of African American ethnicity were found to have lower mortality rates in convulsive SE compared to children of other ethnic groups. In a retrospective study analyzing risk factors for mortality in status epilepticus in Richmond, Virginia, African American ethnicity was found to correlate with decreased mortality risk in univariate, though not multivariate, analysis [@pone.0047474-DeLorenzo1]. While they may have decreased risk of mortality compared to other racial groups, African American children have also been noted to present in SE disproportionately more frequently [@pone.0047474-Wu1], [@pone.0047474-DeLorenzo2]. Because decreased mortality in status persisted in spite of consideration of socioeconomic factors, a heritable resistance to seizure-related mortality in this population cannot be ruled out.

### Sex {#s4c2}

The importance of gender in the risk assessment of SE is debated. While some studies have identified that males are more likely to present in status [@pone.0047474-Knake1], other studies have found the opposite [@pone.0047474-Logroscino2]. Mortality outcomes in status epilepticus between males and females are similarly conflicting [@pone.0047474-Wu1], [@pone.0047474-Koubeissi1], [@pone.0047474-Logroscino1]. While our study found that more males presented in SE than females, we did not find sex to be a significant risk factor in predicting mortality outcomes.

### Age {#s4c3}

Some studies have found an association between SE mortality and children of younger ages [@pone.0047474-Chevrie1], whereas others have noted that older patients have a higher risk of death during SE [@pone.0047474-Koubeissi1], [@pone.0047474-DeLorenzo1]. SE is also noted to occur more frequently in younger patients [@pone.0047474-Koubeissi1]. Age was not found to be a significant independent risk factor for death in our study.

Hospital Data {#s4d}
-------------

### Time of Year {#s4d1}

We tested each month individually as a predictor of mortality and subsequently tested statistically significant months in the multivariable mortality model to account for potential seasonal variations in disease severity, as may occur with infectious or epidemic disease processes. Hospital admissions for convulsive SE during the month of December were associated with an increased risk of mortality. More research will be needed to verify these data and to identify possible causes. Seasonal variations in infections such as bacterial meningitis [@pone.0047474-Sharip1] and viral encephalitis [@pone.0047474-Day1] and other respiratory tract infections may have played a role in this annual variation.

### Teaching and Children\'s Hospitals {#s4d2}

The univariate analysis identified a significant association between deaths and admission into Teaching Hospitals, Children\'s Hospitals and General Hospitals with a Children\'s unit. In addition, referrals from outside hospitals are also associated with significant mortality. None of these factors emerged as significant in the multivariate analysis. We believe that some these findings may be related to referral bias, as more severe cases of SE are likely to be referred to Children\'s Hospitals and teaching institutions.

Comorbidities {#s4e}
-------------

### Symptomatic epilepsy {#s4e1}

Structural brain lesions, as demonstrated by imaging or autopsy findings, emerged as a risk factor for death in our study. This finding is in concordance with results from previous studies suggesting higher mortality in convulsive SE patients with structural lesions, such as brain tumors [@pone.0047474-Logroscino1], cerebral dysgenesis [@pone.0047474-Aicardi1], [@pone.0047474-Barnard1]\_ENREF_13, neurodegenerative disease [@pone.0047474-Logroscino1], cerebral palsy [@pone.0047474-Aicardi1] or other brain malformations [@pone.0047474-Chevrie1]. Mortality may be higher in patients with acute symptomatic SE and neurological injury [@pone.0047474-Kang1].

### Pulmonary complications {#s4e2}

Aspiration was a common comorbid condition associated with death in pediatric patients with convulsive SE. The risk of aspiration was specifically found to be an independent risk factor for mortality in our study. Pneumonia was identified as a cause of death in a prior retrospective pediatric study [@pone.0047474-Barnard1], a pediatric prospective study [@pone.0047474-Callenbach1], and in a pediatric drug trial for management of status epilepticus [@pone.0047474-Brevoord1]. In our population it is unclear how many cases of pneumonia were causes or consequences of SE.

### Sepsis and hemodynamic compromise {#s4e3}

Sepsis emerged as an important risk factor for death in our pediatric population. Sepsis may occur as a consequence of pneumonia or from other infective foci. A retrospective study on pediatric ICU patients identified sepsis to be a major cause of death in children with prolonged (\>45 minute) episodes of SE [@pone.0047474-Gulati1]. Another study on emergency management procedures in children presenting with SE also identified sepsis as a risk factor for death [@pone.0047474-Chin1].

Infections may also be an important cause of SE, particularly in cases that were presumably induced by febrile illness or pneumonia [@pone.0047474-Molinero1]. Our study also identified postoperative sepsis with liver failure to be significant enough to constitute an independent risk factor, and this finding is also backed by a previous pediatric case series [@pone.0047474-Kramer1] and by another series on refractory pediatric SE [@pone.0047474-Sahin1]. Hemorrhagic shock was identified as a risk factor for death. In a trial comparing the use of phenytoin and midazolam in school-age children, hemorrhagic shock was noted as a cause of death [@pone.0047474-Brevoord1].

### Metabolic complications {#s4e4}

Hypoglycemia emerged as an independent risk factor for death in pediatric convulsive SE. Hypoglycemia increased the risk of neurological sequelae in a prospective study in children [@pone.0047474-Sadarangani1]. Hypoglycemia may also be a cause of SE [@pone.0047474-Mah1], [@pone.0047474-DeLorenzo2]. Metabolic complications were associated with an increased risk of mortality using univariate analysis. Previous work has noted similar findings [@pone.0047474-Brevoord1] and has more specifically associated deaths to hyponatremia [@pone.0047474-Chin1]. Liver dysfunction, as mentioned above, is another potential source of metabolic dysfunction.

### Near drowning {#s4e5}

Convulsive SE related to near-drowning episodes constituted an independent risk factor for mortality in our series and other studies [@pone.0047474-Berg2]. Near-drowning episodes may occur as a consequence of seizures [@pone.0047474-Ryan1]. Conversely, SE may also occur as a result of cerebral anoxia following such an event [@pone.0047474-Wilson1].

### Intracranial infections {#s4e6}

The importance of brain infections in leading to SE or resulting in mortality has been noted in previous studies. A prospective pediatric study identified meningitis and encephalitis as causes of SE. Meningitis was also an important risk factor for death [@pone.0047474-Dunn1]. Similar findings have been noted in prospective [@pone.0047474-Sadarangani1] and retrospective [@pone.0047474-Chin1] pediatric studies. Human immunodeficiency virus-associated encephalitis was identified as a cause of SE in one previous pediatric study [@pone.0047474-Sahin1]. In our present data sample, we found intracranial infections, such as viral encephalitis and infectious encephalopathy, to be associated with mortality. These factors did not emerge as independent risk factors for death in multivariate analysis in this series.

### Other comorbidities {#s4e7}

Brain herniation was associated with an increased risk of death. Transtentorial herniation was identified as a long-term cause of death in a prior retrospective pediatric study [@pone.0047474-Callenbach1]. Similarly, subdural hematoma, noted as a cause of death in a previous pediatric case series [@pone.0047474-Morrison1], was associated with mortality in our study. However, these factors were not found to be a significant risk factor for death in multivariate analysis. Unlike prior studies [@pone.0047474-Waterhouse1], patients with status following drug withdrawal did not have a higher mortality rate in this dataset.

Procedures {#s4f}
----------

### Blood Transfusion {#s4f1}

We identified blood transfusion as a factor for fatalities. This additional risk is probably not a result of the transfusion in itself but is likely a marker for the poor clinical condition of certain patients who subsequently require greater intervention. While this finding was not corroborated by prior research, studies investigating patients with related markers of disease severity, such as those investigating ICU patients, have similarly high death rates [@pone.0047474-Gulati1], [@pone.0047474-Brevoord1].

### Mechanical Ventilation {#s4f2}

The need for ventilatory support in convulsive SE may arise from poor respiratory drive resulting from seizure complications or in the context of pharmacological coma induction. The risk of death in mechanical ventilation may be related to the risk of aspiration and impaired mucociliary clearance, leading to pneumonia [@pone.0047474-Konrad1]. Additionally, mechanical ventilation is also associated with complications such as pneumothorax and ventilator-associated lung injury. We confirmed mechanical ventilation as an independent risk factor for death in SE. Mechanical ventilation was associated with death in a prospective study that included adolescents and children [@pone.0047474-Li1]. Similar findings were noted in a randomized control trial comparing antiepileptic medications in the treatment of SE [@pone.0047474-Prasad1].

### Risk factors assessment in SE {#s4f3}

We investigated diagnostic entities due to their known association with high risk of mortality. The KID mentions all diagnoses encountered during a hospital admission irrespective of the cause-effect relationship between SE and associated diagnoses. Entities such as near drowning, hemorrhagic shock, structural brain lesion, and hypoglycemia (likely causes of SE), as well as sepsis, prolonged mechanical ventilation, and transfusion (likely resulting from SE or its treatment) increased mortality in children with convulsive SE. Awareness of these risks may thus promote more improved targeted management towards correcting these conditions.

### Challenges {#s4f4}

The findings of this study need to be interpreted in the setting of data acquisition and subsequent analysis. Misclassification of seizures and comorbidities in the ICD-9 coding system is a potential source of error, as it is with all large databases studies. Multiple criteria exist to diagnose SE. While the Working Group of SE of the Epilepsy Foundation of America defines SE as a seizure of at least 30 minutes duration or multiple seizures without full recovery of consciousness in between [@pone.0047474-Working1], other investigators advocate a cutoff time as short as five minutes [@pone.0047474-Lowenstein1]. Individual physicians may not use the same operational definitions, leading to variations in case reporting. The KID dataset lacks information on the timing of procedures, such as blood transfusion and intubation, which may also be important variables in determining the risk of death in SE. Patients who suffer from SE are noted to have an increased risk of dying that extends to weeks, and possibly years, after discharge [@pone.0047474-Logroscino3]. This information is unavailable in the KID dataset. Because there are no unique patient identifiers in the KID dataset, it was not possible to account for multiple episodes of SE in the same patient. While neonates were included in this study, there is a lack of consensus on the definition of SE in these patients. This study was unable to investigate certain variables, such as seizure duration, and some etiologies, such as cerebrovascular accidents and malaria, which have been identified as important risk factors in other studies due to few numbers of these cases.

Conclusion {#s5}
==========

Convulsive SE is a rare but serious condition and results in approximately 0.1% of all pediatric inpatient hospital admissions. It is fatal in approximately 1% of cases. The rarity of this condition makes it a difficult subject to study. The use of large nationwide databases, such as the KID dataset permits identification of factors associated with increased mortality.

The findings from this study suggest new directions for research. Research should be done to determine which interventions may lead to improved outcomes. More data are needed to ascertain risk factors for long-term mortality in pediatric SE. Parallel research using large groups of adults should be done to establish risk factors for poor outcomes in this group. This may also help to identify risk factors that overlap between pediatric and adult populations. Prospective multicenter studies evaluating children presenting in SE may assist in better determination of risk factors for death and identify those interventions which best promote patient survival.

Our results may also carry implications for improvement of patient care. It is likely that in-hospital mortality of SE is largely a function of the underlying cause of the SE, while other factors may also have an impact on outcome. Some of these risk factors may be ameliorated with specific therapy. Mild induced hypothermia, for example, may be beneficial in patients with near-drowning episodes [@pone.0047474-dePont1]. Early identification and treatment of some of these aggravating factors may not only prevent immediate mortality, but it may also reduce long-term complications and limit neurological dysfunction. Beyond these implications, the development of treatment paradigms may also help reduce variability in care and outcomes and thereby decrease hospital costs. This research may lead the development of warning algorithms which may in turn promote early interventions that reduce ICU admissions, other medical complications, and even death. Identification of risk factors is thus an important first step towards providing improved care when caring for pediatric patients with SE.

The authors would like to acknowledge the Healthcare Cost and Utilization and Project (HCUP) for provision of the KID Inpatient Database for this study.

[^1]: **Competing Interests:**TL serves on the Laboratory Accreditation Board for Long Term (Epilepsy and ICU) Monitoring (ABRET), performs Video EEG longterm monitoring, EEGs, and other electrophysiological studies at Children\'s Hospital Boston and bills for these procedures (20%). He has received investigator initiated research support from Eisai Inc. Dr. SK performs Video EEG longterm monitoring, EEGs, and other electrophysiological studies at Children\'s Hospital Boston and bills for these procedures. He also serves on the editorial board of the Journal of Pediatric Neurology. Dr. MK is on the Speakers\' Bureaus of UCB and Pfizer. There are no patents, products in development or marketed products to declare. This does not alter the authors\' adherence to all the PLOS ONE policies on sharing data and materials.

[^2]: Conceived and designed the experiments: TL TS SR DG ST SK AA MK. Performed the experiments: TS DG ST AA. Analyzed the data: TS DG ST AA. Wrote the paper: SR TL MK TS.
